Sharemaestro Newsreel

Cigna’s Express Scripts Pressured Over TRICARE Contract in Senate Hearing

During a Senate hearing, Cigna's Express Scripts faced intense scrutiny regarding its TRICARE contract, with lawmakers raising concerns about potential overcharging of taxpayers and military families, and underpayment of independent pharmacies. Senators questioned the company's contract provisions allowing retroactive reimbursement adjustments and the inherent …

Bernstein Adjusts UnitedHealth Price Target to $512 From $492, Maintains Outperform Rating

Bernstein has increased its price target for UnitedHealth Group Inc. (UNH) to $512, up from the previous $492. The firm reiterated an "Outperform" rating on the stock. This adjustment reflects Bernstein's continued positive outlook on the managed healthcare provider.

Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?

Elevance Health Chairman Ramiro G. Peru recently purchased 1,000 shares of the company's common stock for $366,050, increasing his direct holdings by 10% to 10,908 shares, now valued at approximately $4.03 million. This insider purchase is viewed as a bullish signal, as insiders typically …

(OSCR) Movement as an Input in Quant Signal Sets

This article analyzes Oscar Health Inc. Class A (NASDAQ: OSCR) using AI models to generate trading strategies and multi-timeframe signal analysis. It highlights weak near-term sentiment but strong long-term potential, providing specific entry zones, targets, and stop losses for position trading, momentum breakout, and …

UnitedHealth Group stock trades steady as investors weigh Optum growth and Medicare headwinds

UnitedHealth Group's stock performance balances Optum's strong growth with challenges like Medicare headwinds and rising medical costs. The company's strategy focuses on integrating its UnitedHealthcare insurance and Optum health services segments, with Optum driving higher margins and diversification. Investors monitor financial metrics like revenue, …

Apple, UnitedHealth Group And A Basic Material Stock: CNBC’s ‘Final Trades’

CNBC's "Final Trades" featured Apple, UnitedHealth Group, and Rio Tinto Group. Apple received an upgrade from HSBC to Buy with a raised price target due to its expanding legal actions against OpenAI. UnitedHealth Group reported strong Q2 results, beating analyst estimates and raising its …

AE1J Bond Profile — Key Metrics

This article provides a detailed profile of the Elevance Health, Inc. 4.375% bond maturing on December 1, 2047, traded as AE1J on the Munich Stock Exchange. It includes key figures such as the issue date, outstanding amount, face value, coupon rate, and offers a …

Heartland Advisors Inc. Sells 2,535 Shares of Humana Inc. $HUM

Heartland Advisors Inc. reduced its stake in Humana Inc. (NYSE:HUM) by 10.6% in the first quarter, selling 2,535 shares and retaining 21,353 shares valued at $3.7 million. Other institutional investors like Watershed Asset Management and Hartford Funds Management Co LLC also made significant moves …

Centene stock trades steady as Medicaid and marketplace growth shapes 2026 outlook

Centene Corp. is navigating the complexities of Medicaid redeterminations and marketplace enrollment while also growing its Medicare business, as highlighted by its 2025 results and 2026 guidance. The company's revenue growth is supported by government programs, with marketplace expansion helping to offset some impacts …

Dividend Investors: Don't Be Too Quick To Buy CVS Health Corporation (NYSE:CVS) For Its Upcoming Dividend

How Molina Healthcare Inc (MOH) Affects Rotational Strategy Timing

This article analyzes Molina Healthcare Inc (MOH) using AI models to provide trading strategies and signals. It notes conflicting sentiment across different time horizons, suggesting choppy market conditions for MOH. The analysis offers specific long, breakout, and short strategies with entry, target, and stop-loss …

Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors who purchased Humana Inc. (NYSE:HUM) securities prior to June 27, 2022, and continue to hold them. The investigation focuses on whether Humana and its officers engaged in corporate wrongdoing. The firm …

Elevance Health President Acquires 1.9% More Stock

The President of Elevance Health, Morgan Kendrick, has increased his holdings in the company by 1.9% through a recent stock acquisition. This transaction involved Kendrick buying 1,775 shares at a price of $481.56 per share. Following this purchase, his total direct share ownership stands …

Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors

Progyny's COO, Melissa B. Cummings, sold 3,437 shares of common stock worth approximately $109,000 on July 14, 2026. This transaction, which reduced her direct holdings by 5%, was conducted as part of a pre-established Rule 10b5-1 trading plan and for tax obligations. The article …

Cigna Group stock trades steady as earnings growth and buybacks support valuation

Cigna Group's stock performance is supported by strong earnings growth in its health services and insurance operations and significant capital returns. The company reported adjusted income from operations of $7.3 billion in 2023, with a projection of at least $8.0 billion for 2024, alongside …

Swiss National Bank Has $267.56 Million Holdings in CVS Health Corporation $CVS

The Swiss National Bank increased its stake in CVS Health Corporation by 7.2% in Q1, bringing its total holdings to 3.73 million shares valued at approximately $267.6 million. This comes as CVS reported strong quarterly results, beating revenue and EPS estimates, and issued a …

Centene stock trades steady as Medicaid and marketplace membership support recent earnings momentum

Centene stock's recent performance is influenced by its strong presence in Medicaid and Affordable Care Act marketplaces, alongside disciplined cost control. The company, a major US managed care provider, focuses on government-sponsored health plans and aims to simplify its structure while managing the complexities …

CVS Health Corporation $CVS Shares Acquired by AIA Group Ltd

AIA Group Ltd significantly increased its stake in CVS Health Corporation by 104.8% in the first quarter, now owning 177,654 shares valued at $12.76 million. Other institutional investors also adjusted their positions in CVS Health, with hedge funds and institutional investors collectively owning 80.66% …

agilon Health (AGL) Stock Looks Undervalued On Sales But Rich After A 7x Run

agilon health (AGL) has seen a significant 671% return year-to-date, but despite this, Simply Wall St's analysis suggests the stock remains undervalued based on sales multiples. The company's P/S ratio (0.4x) is well below the industry average, indicating that the market might be cautious …

CGRO ETF Profile: Dividends, Returns (NEO:CGRO)

This article provides a profile of the CI Growth Asset Allocation ETF Trust Unit (NEO:CGRO), detailing its investment strategy, key statistics, and performance. The fund aims for long-term capital growth by investing in global equity and fixed income ETFs, with an active management style. …

Cigna (CI) Stock May Trade At A Discount Despite A 33% Five Year Gain

Cigna Group (CI) has seen a 32.5% gain over the past five years, yet its stock, currently at US$281.45, appears undervalued based on various valuation tests. The company's P/E ratio of 11.8x is significantly lower than the Healthcare sector average and an implied fair …

Cigna Group (CI) Revenue Breakdown - Main Composition

NULL

CVS Caremark Mail Service Pharmacy by CVS Health Corp. - steady B2B engine for prescriptions

The article describes CVS Caremark Mail Service Pharmacy as a crucial business-to-business (B2B) engine for CVS Health Corp., handling millions of maintenance prescriptions primarily for employers and health plans in the United States. This service focuses on high-volume, automated mail dispensing of medications, aiming …

Watershed Asset Management L.L.C. Takes $474,000 Position in Humana Inc. $HUM

Watershed Asset Management L.L.C. recently initiated a new position in Humana Inc. (NYSE:HUM), purchasing 2,735 shares valued at approximately $474,000 during the first quarter. This aligns with a broader trend of institutional investment, as institutions now own 92.38% of Humana's stock. The insurance provider …

Putnam Master Intermediate Income Trust Declares Monthly Distribution, Payable on June 1, 2021

Putnam Master Intermediate Income Trust (which will change its name to Franklin Master Intermediate Income Trust) announced a monthly distribution of $0.0220 per share, payable on June 1, 2021. The record date for this distribution is May 24, 2021, and the ex-date is May …

Molina Healthcare stock trades steady as Medicaid margin focus follows recent earnings

Molina Healthcare's stock performance currently reflects a balance between growth in Medicaid and Medicare memberships and the critical need for strict cost control. The company's recent quarterly earnings show significant revenue, but also highlight the narrow operating margins typical of the government-sponsored health insurance …

Elevance Health CEO Snaps Up Stock After Post-Earnings Slide

Elevance Health's CEO, Gail Boudreaux, purchased $1 million worth of company stock following a decline in share price after the health insurer's second-quarter earnings report. This marks her first stock acquisition for the year.

Cigna Group (CI) Faces A Valuation Test, Is The Recent Pullback A Buying Opportunity?

Cigna Group (CI) has seen recent share movements, with the stock closing at US$281.45. Despite a recent pullback, a popular narrative suggests the company is 17.4% undervalued, with a fair value closer to $340, driven by long-term earnings and cash flow expectations and strong …

Did Rising Analyst Earnings Estimates and Zacks Rank Upgrade Just Shift Humana's (HUM) Investment Narrative?

Can Molina Healthcare (MOH) Trade At A Premium After Its Contract Win?

Clover Health CEO, Medicare Advantage Jamie L. Reynoso disposes of 4,839 shares for $21,920.67

Jamie L. Reynoso, CEO of Clover Health Medicare Advantage, sold 4,839 Class A common shares on July 17, 2026, for a total of $21,920.67 at a price of $4.53 per share. Following this transaction, Reynoso's direct stake in Clover Health fell to 2.81 million …

Insider Buying: Ramiro Peru Acquires Shares of Elevance Health I

Ramiro Peru, a Director at Elevance Health Inc (ELV), recently purchased 1,000 shares, increasing his total holdings to 10,908 shares. This transaction follows a pattern of insider buying within the company, which has seen five insider buys and five insider sells over the past …

What’s A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?

Elevance Health reported a strong quarter with raised profit forecasts, yet its stock plunged 8.5% due to significant issues in its Medicaid division. The company is facing a negative Medicaid operating margin and plans to exit several Medicaid markets, indicating a strategic retreat from …

Clover Health Investments (CLOV) insider sells 4,839 shares under 10b5-1

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. (CLOV), sold 4,839 shares of Class A Common Stock on July 17, 2026. The shares were sold at a weighted average price of $4.53 per share, ranging from $4.35 to $4.63, as …

Elevance Health director Peru buys $366,050 in company stock

Ramiro G. Peru, a director at Elevance Health, Inc. (NYSE:ELV), recently purchased 1,000 shares of the company's common stock for $366.05 per share, totaling $366,050. This transaction occurred on July 17, 2026, and increased his direct ownership to 10,908 shares. The purchase follows a …

Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?

Elevance Health CEO Gail Boudreaux recently purchased 2,725 shares of the company's stock for approximately $1 million, increasing her total equity stake by 2%. This insider purchase is seen as a bullish signal for the company's 2026 outlook, especially in light of positive trends …